(The Wistar Institute) In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells (‘TABs’) in melanoma progression and resistance to targeted therapy.